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Abstract The voiding cystourethrogram (VCUG) is a
widely used study to define lower urinary tract anatomy
and to diagnose vesicoureteric reflux (VUR) in children.
We examine the technical advances in the VCUG and other
examinations for reflux that have reduced radiation expo-
sure of children, and we give recommendations for the use
of imaging studies in four groups of children: (1) children
with urinary tract infection, (2) siblings of patients with
VUR, (3) infants with antenatal hydronephrosis (ANH),
and (4) children with a solitary functioning kidney. By
performing examinations with little to no radiation, care-
fully selecting only the children who need imaging studies
and judiciously timing follow-up examinations, we can
reduce the radiation exposure of children being studied
for reflux.
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Introduction
The traditional method for diagnosing vesicoureteric reflux
(VUR) is the fluoroscopic voiding cystourethrogram
(VCUG). This study is primarily used to screen children
who are at risk of VUR and to provide detailed anatomical
information on the genitourinary system. Because this
examination is mainly performed in children, who are at
greatest risk of the harmful effects of ionizing radiation, we
must find ways to achieve diagnostic accuracy while
minimizing radiation dosage.
In this article, we review the technical advances in the
diagnosis of VUR and present recommendations for the
evaluation of four groups of children widely studied for
reflux: (1) children with urinary tract infection (UTI), (2)
siblings of patients with VUR, (3) infants with antenatal
hydronephrosis (ANH), and (4) children with a solitary
functioning kidney. In addition, we discuss the timing and
frequency of imaging studies to detect VUR resolution. By
defining patients at risk of reflux and determining the
differences between patient groups, we can utilize studies
judiciously and minimize radiation exposure. Our recom-
mendations are based on the imaging studies available at
our hospital. The ultimate choice of imaging modality
depends on diagnostic availability, the individual patient
and the referring physician’s preference.
Technical advances in voiding cystography
In the last two decades enormous strides have been made in
reducing the radiation dosage in patients studied for VUR.
The improvement has been a result of replacement of
standard fluoroscopic machines with digital and pulsed
fluoroscopy, judicious use of radionuclide cystograms
(RNC), and the introduction and growing popularity of
voiding urosonography (VUS).
A traditional VCUG exposes the patient to 100 times the
radiation of an RNC. In the last 10 years, low-dose
fluoroscopy techniques, including digital fluoroscopy and
pulsed fluoroscopy, have led to a decrease in the radiation
dose to the patient [1–5] while providing similar diagnostic
quality images [6–10]. By changing from continuous to
pulse fluoroscopy, the effective dose of radiation can be
reduced by approximately 90% with minimal loss of
resolution [10]. Pulsed fluoroscopy is now considered a
requisite for optimal pediatric fluoroscopy [11].
Digital fluoroscopy offers the advantage of “image or
screen save” so that the last image can be saved without
additional radiation to the patient. Limiting the number of
spot images and maximizing the number of image-save
acquisitions decreases radiation [12]. Meticulous image
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coning also significantly decreases patient radiation
exposure. Thus low magnification, low-pulse-per-second
fluoroscopy and image-save acquisition should be used
when performing a VCUG.
In our department, the effective radiation dose of a
VCUG using modern low-dose fluoroscopic methods is
approximately 10 times that of RNC (mentioned below).
For example, the average effective dose of a VCUG in a
3-year-old patient is 3 mrem, compared to 0.5 mrem for an
RNC. For comparison, the average effective dose of an
airplane ride from Boston to San Francisco is 5 mrem. The
average effective dose of the VCUG is variable and
depends on the patient size, operator and machinery.
The main advantage of RNC over fluoroscopic VCUG is
decreased radiation exposure of the patient. The sensitivity
of RNC for detecting reflux is equal to or greater than that of
VCUG; however, the spatial resolution and anatomic detail
seen on an RNC are inferior to those seen on a VCUG. To
increase the sensitivity of either test, a cyclic study should be
performed in children younger than 1 year [13].
In order to avoid instrumentation, methods of indirect
cystography have been tested. Indirect cystography uses
intravenously injected Tc 99m pentetate, which is cleared
by the kidneys into the bladder to assess for reflux without
bladder catheterization. Unfortunately, this method has a
high percentage of false-negative studies, so it is not
recommended.
During the last two decades, in an effort to eliminate the
radiation exposure intrinsic to RNC and VCUG, sonography
has been used to evaluate reflux. Indirect US methods
without the use of contrast agents avoid instrumentation but
are significantly less sensitive [14–16]. A normal non-
contrast US scan of the urinary tract without contrast agent
does not exclude reflux [17]. The availability of a stable US
contrast agent that can be administered intravesically is a
great breakthrough that has popularized VUS [18]. During
contrast sonocystography, the bladder is filled through a
catheter with a US contrast agent, and reflux is assessed by
the sonographic appearance of contrast agent within the
kidneys and ureters. The grading system is similar to that for
a VCUG [19]. This method is not as popular in North
America as elsewhere in the world. In some German
institutions, this method has led to a significantly reduced
number of VCUGs and the associated ionizing radiation
[20].
There is a 92% concordance in VUR diagnosis on VUS
and VCUG/RNC [18, 21, 22]. In comparison to VCUG, the
sensitivity and specificity of VUS range from 88% to 100%
and 86% to 100%, respectively [18]. Although comparable
to VCUG and RNC in sensitivity and accuracy in detecting
VUR [23–30], VUS as compared to a VCUG does not
provide comparable anatomic detail of the bladder, ureter,
and urethra. Current recommendations for the use of VUS
vary.
During MR cystography, images of the genitourinary
tract are obtained before and after the intravesical
administration of gadolinium and after voiding. The
method is less sensitive than VCUG for detecting reflux
and is experimental. The relative benefits of this examina-
tion are that it exposes the child to no additional radiation
and can evaluate the kidneys for changes related to reflux
nephropathy [31, 32]. However, the sedation or anesthesia
often required in the young patients evaluated by MRI
imposes medical risks and costs time and resources.
Children with urinary tract infection
Most UTIs in children are ascending and related to factors
such as dysfunctional voiding or impaired lower tract
defenses. The VCUG has been regarded as fundamental in
evaluating the child with a well-documented UTI because
it evaluates: (1) bladder and urethral anatomy, (2) bladder
capacity, (3) ability of the bladder to empty, (4) presence of
VUR, and (5) the grade of VUR.
Although cystitis alone does not pose a significant threat
to the health of a child, a UTI combined with VUR can
result in significant renal damage. VUR is present in
30–50% of children with a febrile UTI [33]. Studies
demonstrate that on initial evaluation of children with a
febrile UTI and VUR there is up to a 40% incidence of
renal scarring [34]. Although the majority of VURs resolve
spontaneously with time, the likelihood of resolution
depends on age at diagnosis, laterality and VUR grade.
In addition, as children get older, they are much less likely
to have VUR, because if they had it, it has resolved (Fig. 1)
[35]. The VCUG provides critical prognostic information
by detecting and then defining the severity of VUR.
The VCUG is invasive in terms of instrumentation and
radiation exposure; therefore, selectivity in its application
is appropriate. The greatest reduction in radiation exposure
occurs by avoiding the study altogether. Critical to
determining which patients require a VCUG is the
Fig. 1 Graphical representation of VUR prevalence determined
from 54 studies weighted by sample size of children with UTI
(reproduced with permission from Pediatrics vol. 103, pp 843–852,
copyright 1999 by the AAP)
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definition of a UTI. Urine specimens obtained by
catheterization or suprapubic aspiration are the gold
standard. Any significant pure growth from a catheterized
specimen or suprapubic aspiration is regarded as positive.
A bacterial count of >105 cfu/ml from a clean midstream
collection has an 80% (and two such collections a 90%)
likelihood of representing a true infection [35]. Specimens
that are obtained by adhering a plastic bag to the perineum
are useful only if no organisms grow, as any bacterial
growth usually reflects perineal flora. Contamination rates
range from 60% to 70% [36]. Results from catheterization
through a phimotic foreskin can also be misleading.
In addition, clinical presentation, age, race and social
factors contribute to selecting which patients should have a
VCUG. The combined presence of fever (>38.5°C) [37]
and UTI are important clinical findings, as they might
indicate a pyelonephritis as opposed to cystitis, which
typically does not produce fever. Pyelonephritis can result
in significant kidney damage unless prompt antimicrobial
therapy is instituted. Children with repetitive febrile UTI
are at further increased risk of renal damage. Therefore, in
the young child with a febrile UTI, cystographic evaluation
to rule out VUR is most strongly warranted.
Recently, attempts to link biomarkers of inflammation
such as procalcitonin, known to be associated with renal
scarring, have shown promise in attempting to stratify
patients by risk of renal damage [38]. Further investigation
is needed to accurately stratify patients by their risk of renal
damage.
The greatest risk of renal damage is during the first
2 years of life. Therefore, we recommend aggressive
screening of children <2 years of age, because of their
increased risk and inability to describe symptoms. For
prepubertal boys with a well-documented UTI, the VCUG
is the preferred diagnostic study so that the urethral
anatomy might be defined. In less well-documented cases,
an initial renal bladder US is reasonable. For prepubertal
girls with pyelonephritis, the VCUG is recommended,
whereas for prepubertal girls with recurrent lower UTI and
the ability to describe symptoms (>5 years of age) an RNC
is recommended. If the veracity of the diagnosis of UTI in a
girl is questioned, a US is a proper initial study.
Postpubertal children are at minimal risk of renal
scarring and do not require diagnostic imaging when
presenting with cystitis. Similarly, because of the low
incidence of reflux in black children, the black child
between the age of 5 years and puberty presenting without
fever but with infection do not require a VCUG [39]. In
settings where parental vigilance is questionable, an
aggressive approach should be considered.
Sibling vesicoureteric reflux
VUR is the most common heritable disorder of the
genitourinary tract, but has not been linked to a particular
chromosome or genetic defect. A recent research synthesis
of 1,768 siblings of various ages showed a mean VUR
incidence of 32% [40]. The research demonstrated that
certain factors help predict the risk of sibling VUR. When
stratified by sibling age, 44% of children <2 years of age
have VUR, as opposed to 9% of children >6 years [40]. If
the sex of the sibling or index patient is considered
individually there is no statistically significant difference in
VUR risk; however, if the sex of both patients is
considered, female siblings of female index patients are
at higher risk of VUR than their male counterparts [41].
Twins are at particularly increased risk, and monozygotic
twins are at higher risk than dizygotic twins [42, 43].
Approximately two-thirds of sibling VURs are low-grade
(I/II) and half are unilateral [40]. Sibling VUR shows an
inverse relationship between age and grade of reflux [44].
Although the data are limited, siblings might have a higher
resolution rate as compared to children discovered after a
febrile UTI [40].
Although the incidence of VUR in siblings is signifi-
cantly higher than in the general population, the majority of
sibling VUR is asymptomatic (no history of UTI) and
might be innocuous. Hollowell and Greenfield [40]
determined from the literature an 11% incidence of renal
damage documented by various radiographic modalities in
which the majority of patients were asymptomatic [40].
Furthermore, Puri et al. [45] demonstrated that symptom-
atic siblings (history of febrile UTI) not only have higher
grades of VUR but also an increased rate of reflux
nephropathy (25%) as compared to reported data on
asymptomatic siblings. Therefore, the early detection of
VUR in asymptomatic siblings might decrease the inci-
dence of renal damage [46].
Although the goal of screening for sibling VUR is the
prevention of renal damage, no current genetic tests can
determine who is at risk of renal damage, let alone which
siblings will have VUR. Based on the literature, we have
divided children into four groups for potential screening:
(1) newborns to the age of toilet training, (2) prepubertal
children older than toilet-training age, (3) postpubertal
children, and (4) any symptomatic sibling. The age of toilet
training is chosen because typically at this age children can
describe their symptoms and parents can detect signs of
UTI such as frequency.
All children should be initially screened by an extensive
history including voiding habits and any unexplained
febrile events. We recommend elective screening with
RNC for both girls and boys, because RNC is a sensitive
examination for VUR and confers a very low dose of
radiation. In the future, VUS might be a viable alternative
to the RNC.
Because the prevalence of VUR drops considerably with
increasing age (Fig. 1) for prepubertal children older than
toilet training age (group 2), we recommend an initial
screening US scan. If the renal US scan demonstrates
abnormalities, such as size discrepancy, renal malformation
or scarring, dilated ureter, hydronephrosis or change in
renal pelvis or ureteral caliber during the examination, we
recommend an RNC. If VUR is discovered, the follow-up
study at 1 year should be a VCUG to more clearly define
the genitourinary anatomy.
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We accept that ultrasonography is not as sensitive as
DMSA for the detection of renal scars in patients with a
history of acute pyelonephritis; however, the role of
evaluating the asymptomatic patient sonographically as
compared to DMSA has not been defined [47–49]. If the
sibling population has remained asymptomatic during the
most vulnerable period for renal damage secondary to
infection and reflux, the value of conducting a DMSA scan
as the initial screening test is low.
Vulnerability to renal damage is thought to persist until
puberty [50, 51]. Taking this into consideration, with the
decreasing incidence of reflux with age and the possible
higher resolution rate of reflux in siblings, we recommend
that asymptomatic postpubertal boys and girls be screened
with a renal US scan only (group 3). We especially
recommend screening of girls because of the increased risk
of UTI during their reproductive years and the deleterious
effects of an upper UTI during pregnancy. If there are
no renal abnormalities, we recommend no further inves-
tigation unless symptoms develop. If abnormalities are
found on sonography, we recommend a VCUG or RNC.
Symptomatic siblings (group 4) need to be studied
aggressively and treated as any other child with a UTI.
Antenatal hydronephrosis and vesicoureteric reflux
ANH affects 1–5% of all pregnancies and is one of the most
common prenatally detected abnormalities; however, the
clinical relevance of varying degrees of ANH is unclear
[52–61]. Although the prenatal US scan is noninvasive and
without ionizing radiation, postnatal assessment can be
invasive and expose the child to radiation. To date there are
no large comprehensive prospective studies that have
determined the risk of VUR with varying degrees of ANH.
Similarly, there are no large studies that have examined
both ANH and postnatal US (PNUS) findings to predict
postnatal risk of VUR or kidney damage. There is general
agreement that the postnatal evaluation of children with
moderate to severe ANH that persists postnatally should
include a VCUG. However, the postnatal management of
children with mild ANH, any degree of ANH that resolves
soon after birth, or a nonspecific history of ANH is
controversial.
Numerous small series demonstrate that children with
ANH have an increased risk of VUR as compared to the
general population [62–64]. Overall, boys are thought to be
at greater risk of bilateral high-grade reflux than girls [65].
The largest single series that documented mild ANH and its
relationship to VUR established a 15% incidence of VUR;
however, this series only had 40 patients [63].
Attempts to stratify risk based on PNUS findings have
not been successful [62–64, 66, 67]. Many studies have
shown that a normal postnatal US scan is not a reliable
indicator or predictor for the exclusion of VUR [68–70]. In
one study, hydronephrosis on PNUS had a sensitivity of
63% and specificity of 66% for VUR on VCUG [63].
Although the data are limited, children with ANH and
VUR seemingly have a more benign course with a higher
resolution rate of VUR than children discovered to have
VUR after a febrile infection [71–73].
We provide the following recommendations for the
evaluation of children with ANH with the understanding
that the current literature is controversial and that the care
of each child is individual. Children with bilateral severe
ANH or a solitary kidney with any grade of ANH should
undergo a PNUS shortly after birth, keeping in mind that
physiologic dehydration within the first 5 days might
decrease the degree of hydronephrosis. Those with any
other grade of ANH should undergo a PNUS within the
first month of life. Male and female children with moderate
or severe ANH should undergo a VCUG. Children with
mild ANH that persists after birth might be followed by US
with or without a VCUG or RNC. Management of mild
ANH that resolves is controversial and might require
further imaging.
The solitary kidney
The incidence of VUR in patients with a multicystic
dysplastic kidney (MCDK) or renal agenesis has been
examined in a number of studies. It is logical to do so
because the child’s renal function is entirely dependent
upon the integrity of the solitary kidney such that reflux
nephropathy would have devastating consequences.
The incidence of reflux to the contralateral kidney in a
child with MCDK ranges from 13% to 28% [74–77].
Reflux in the majority of children is mild to moderate in
degree, and the spontaneous resolution rate is high. Renal
agenesis has been evaluated in fewer studies, but the
incidence of VUR appears comparable to that in MCDK
(5–24%) [74–76]. Without doubt, some of these cases
might represent undetectable MCDK. For both MCDK and
renal agenesis, RNC and VUS seem advisable as screening
studies for VUR because the stakes in this group of patients
with a solitary functioning kidney are particularly high.
Timing and frequency of radiologic intervention
for the detection of VUR resolution
The majority of patients with primary VUR are managed
medically with prophylactic antibiotics until either resolu-
tion of VUR or an indication for surgical intervention. The
rate of VUR resolution by grade and laterality has been
well-documented. Nonetheless, guidelines vary consider-
ably regarding the frequency or type of diagnostic imaging
needed to follow VUR until resolution [78–81]. Although
most pediatric urologists and pediatric radiologists recom-
mend annual follow-up studies, this has not been
rigorously tested.
The dilemma has recently been analyzed by modeling, in
both a theoretical and retrospective cohort of children
younger than 10 years with a diagnosis of primary VUR
and febrile UTI, different strategies of VCUG follow-up
and its effects on antibiotic exposure and cost [82]. Based
on their analysis, the authors recommended that patients
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with mild VUR undergo a VCUG every 2 years during
follow-up and every 3 years if reflux was moderate to
severe. The authors made these recommendations by
determining which timing strategy would most effectively
decrease the number of VCUGs and cost per patient while
minimizing increase in antibiotic exposure. Using a small
retrospective cohort of patients with low-grade reflux and a
resolution rate similar to that of published rates they
applied their clinical algorithm and predicted that the
number of VCUGs performed per patient would be reduced
by 19% (P=0.001), the costs reduced by 6% (P=0.17), and
the antibiotic exposure increased by 26% (P=0.001).
With less frequent VCUG follow-up, long-term anti-
biotic exposure will increase significantly in patients who
are compliant. However, it is well-documented that
adherence to medication regimens in children with chronic
diseases is about 50% [83]. The longer they require
medication, the less likely they are to adhere to the regimen
[83]. Although it is difficult to quantify, it is possible that
voiding cystography would serve as a reminder of VUR,
which in turn would improve medication compliance
before VUR resolution.
Without doubt, if we could stratify VUR patients by their
risk of renal damage, we would significantly decrease the
amount of diagnostic imaging performed during medical
management. Some authors have recently questioned the
conventional management of children with low-grade
reflux who might be at a low risk of renal injury; however,
it is still difficult to determine which children are at risk of
damage [84–86].
We recommend that patients with low-grade (I, II)
primary VUR, regardless of laterality, be followed annually
because of the higher resolution rate with lower grades of
VUR. If the initial study to document VUR was an RNC,
we recommend the first follow-up examination be a VCUG
in order to detect any occult bladder or urethral
abnormalities that would decrease the likelihood of VUR
resolution (e.g. hutch diverticulum, posterior urethral
valves). All subsequent follow-up studies should be an
RNC, keeping in mind that grade I reflux is sometimes
difficult to discern on RNC. For patients with moderate to
severe VUR (≥III), a more prolonged resolution period is
anticipated. Initially, anatomical abnormalities need to be
ruled out with a VCUG. At the discretion of the urologist
and taking into consideration family compliance, patient
age, and the logistics of follow-up, an RNC might be
performed every 18 months to 2 years until resolution or
surgical intervention. For patients with bilateral disease, the
higher grade of VUR is the rate-limiting step to resolution
and, therefore, dictates the frequency of follow-up.
For children who undergo antireflux surgery, post-
operative imaging should be an RNC. A VCUG is rarely
indicated, and many pediatric urologists [87] no longer
perform postoperative voiding studies at all. For those who
are committed to documenting the success of surgery, the
VUS might prove to be the ideal study in the future.
Conclusion
Significant technical innovations, such as digital pulsed
fluoroscopy and VUS, and the judicious use of the studies
emitting ionizing radiation have led to the overall decrease
in radiation exposure in children being evaluated for VUR.
In the future, advances in basic science such as genetic
screening and biomarker discovery might help determine
which children are at risk of reflux and renal damage,
potentially replacing our current invasive and radiation-
emitting examinations for reflux.
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